We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Side Effects of Q-Switched Ruby Laser for the Treatment of Lentigines in Light and Dark Skin Types

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00386204
First Posted: October 11, 2006
Last Update Posted: June 4, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Shahid Beheshti University of Medical Sciences
October 10, 2006
October 11, 2006
June 4, 2008
November 2005
Not Provided
  • Clinical Clearance
  • Side Effects
Not Provided
Complete list of historical versions of study NCT00386204 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Side Effects of Q-Switched Ruby Laser for the Treatment of Lentigines in Light and Dark Skin Types
Efficacy and Side Effects of Q-Switched Ruby Laser Treatment of Solar Lentigines in Two Different Fitzpatrick Skin Types II and IV
The purpose of this study is a comparison of efficacy and side effects of Q-switched Ruby laser treatment for solar lentigines in two different skin types II and IV.

It has been widely accepted that dark colored individuals are prone to develop laser induced side effects especially post inflammatory hyperpigmentation(PIH) and it could be a limiting issue in selecting dark colored individuals.

We designed this study to evaluate the difference of efficacy and side effects in light and dark skinned individuals.

Interventional
Phase 2
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single
Primary Purpose: Treatment
Solar Lentigines
Device: Q-switched Ruby Laser
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
90
September 2006
Not Provided

Inclusion Criteria:

  • Solar Lentigines
  • Fitzpatrick skin type II and IV

Exclusion Criteria:

  • Pregnancy
  • Age above 80
  • Photosensitivity
  • Concern for malignancy
  • Active Infection
Sexes Eligible for Study: All
up to 80 Years   (Child, Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Iran, Islamic Republic of
 
 
NCT00386204
src-pts-11073
Not Provided
Not Provided
Not Provided
Not Provided
Shahid Beheshti University of Medical Sciences
Not Provided
Study Chair: Parviz Toossi, M.D. Shahid Beheshti University of Medical Sciences
Shahid Beheshti University of Medical Sciences
June 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP